Introducing
Your new presentation assistant.
Refine, enhance, and tailor your content, source relevant images, and edit visuals quicker than ever before.
Trending searches
A Timeline of HIV/AIDS Education and Research in the U.S
The CDC publishes an article about a rare lung infection in five previously healthy young gay men. This same day, dermatologist Dr. Alvin Friedman-Klein reports a cluster of cases of Kaposi's Sarcoma among gay men in NY and CA.
The Los Angeles Times publishes the first front page story about the AIDS epidemic in mainstream media.
The CDC uses the term "AIDS" (Acquired Immunodeficiency Syndrome) for the first time in a publication and releases a case definition.
Richard Berkowitz and Michael Callen—both men living with AIDS—publish a booklet on “safer sex” titled How to Have Sex in an Epidemic: One Approach.
Ryan White, a 13-year-old hemophiliac, becomes infected after a blood treatment. In 1985, he is barred from school and becomes a spokesperson against stigmatization.
President Ronald Reagan, who was elected in 1980, first mentions the word AIDS in public.
Congress passes the Ryan White CARE (Comprehensive AIDS Resources Emergency) Act, shortly before his death. The act will be reauthorized in 2006 and again in 2009. Ryan White programs became the largest provider of services for people living with HIV/AIDS in the U.S.
AIDS becomes leading cause of death for all Americans ages 25 to 44.
CDC reports the first substantial decline (47 percent) in AIDS-related deaths in the U.S. compared to 1996, largely due to the use of Highly Active Antiretroviral Therapy (HAART.)
President George W. Bush announces the President’s Emergency Plan for AIDS Relief (PEPFAR) and Congress authorizes $18 billion initiative to address HIV/AIDS, making it the largest commitment by any nation for a single disease until COVID-19. It’s estimated that PEPFAR has saved more than 20 million lives through accountable, transparent and cost-effective treatments primarily in sub-Saharan Africa.
U.S. removes travel and immigration ban of HIV-positive non-U.S. citizens from entering the country.
The FDA approves the first at-home HIV test that will let users learn their HIV status right away.
The FDA approves the use of Truvada® for pre-exposure prophylaxis (PrEP). Adults who do not have HIV, but who are at risk for infection, can now take this medication to reduce their risk of getting the virus through sexual activity.
UNAIDS announces that new HIV infections have dropped more than 50% in 25 low- and middle-income countries, and the number of people getting antiretroviral treatment has increased 63% in the past two years.
CDC announces that people living with HIV who are on treatment and have undetectable viral loads have effectively no risk of transmitting the virus to sexual partners.
At the 2019 Conference on Retroviruses and Opportunistic Infections (CROI), researchers announce the second cure of a person with HIV . Like the 2007 case of the “Berlin Patient ” (the first person to be cured of HIV), the “London Patient” has no detectable HIV infection three years after he received a bone marrow transplant from a donor who is genetically immune to HIV, despite having been off antiretroviral therapy (ART) for 18 months.
The world marks 40 years since the first five cases of what later became known as AIDS were officially reported, with President Biden releasing a message recognizing the 40th anniversary. Other events and activities are held across the country.
Studies of PrEP use by risk and race show that African Americans and Latinos account for the smallest number of prescriptions despite being 2/3 of the group that could benefit from preventative medicine;
CDC publishes a new study showing that the age-adjusted rate of HIV-related deaths among people with HIV in the U.S. fell by nearly half from 2010 to 2017, mostly as a result of early testing and diagnosis and helping people access and stay on lifesaving treatment.